Jonathan W. Friedberg, MD, MMSc

Director of the James P. Wilmot Cancer Institute and director of Hematologic Malignancies Clinical Research at the University of Rochester Medical Center in Rochester, New York

From ASH Meeting on Hematologic Malignancies: What is the prognosis for symptomatic, bulky FL that has returned after R-CHOP? Saturday, September 9th, 2017
During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the meeting via an audience response system, but we want to know what you would do. Send in your responses for a chance to win an ASH Clinical News-themed prize!